![Three surgeons wearing masks and gowns work on a patient in the operating room](https://www.uc.edu/news/articles/2023/10/n21205141/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1698672911635.jpg)
UC study: ‘GPS’ seed devices effective in localizing breast tumors
SmartClips improve efficiency, patient comfort, expert says
University of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remove breast and lymph node tumors was safe and effective.
The feasibility study evaluating the use of the devices, called SmartClips, was recently published in the journal The American Surgeon.
UC’s Jaime Lewis and her colleague Elizabeth Shaughnessy helped test the SmartClip devices as they were being developed.
Jaime Lewis, MD. Photo/University of Cincinnati.
“We went a few times and saw the different prototypes, worked with them, and provided feedback. Then we were one of the first institutions to use the SmartClips when they became commercially available in 2020,” said Lewis, a Cancer Center physician-researcher and associate professor of surgery in the UC College of Medicine. “Now, I’ve done more surgeries than any other surgeon with the SmartClip.”
The research team reviewed 100 patients whose tumors were marked, or localized, using SmartClips. Lewis said using SmartClips was equivalent in aiding surgeons in localizing and removing the tumor compared to the traditional technique using a needle and wire and may be safer when used to mark lymph node tumors for excision.
The traditional needle and wire technique is typically done on the day of surgery and can be cumbersome and uncomfortable for patients. SmartClips can be implanted at any time prior to surgery, and Lewis said surgeons can quickly learn the technique needed to use them in the operating room.
Patients definitely seem to be happier, I think surgeons are happier, the radiologists are happier, and it makes the flow of patients through procedures much better.
Jaime Lewis, MD
“The patient doesn’t have this needle and wire coming out of their breast that we’re trying to work around the day of surgery that may limit our ability to use a certain incision,” Lewis said. “There’s always a risk when patients are undergoing localization that they can pass out. So if the localization is performed on a different day, we reduce the need to cancel their surgery and delays in localization don’t slow down the progress of the day.”
Lewis said using SmartClips improves efficiency since radiologists can schedule the implantation when it works best for them, and then the day of surgery is also shorter.
“Most people prefer two visits rather than one very long day, and they like the idea of not having the needle and wire sticking out,” she said. “But I think the real benefits from my perspective are the facilitation of the operative schedule and not interfering with the surgeons’ choice of incision.”
SmartClips are one of a number of devices, including radioactive, radiofrequency and magnetic seeds, that have been introduced to better localize breast tumors. Lewis said the move to these new devices and eliminating the wire and needle technique is a positive development for patients and clinical teams, though a full cost-benefit analysis should be conducted in the future.
“There’s still some technical glitches with it, but I do think that a device like this or another iteration of the future is definitely where we should go,” she said. “Patients definitely seem to be happier, I think surgeons are happier, the radiologists are happier, and it makes the flow of patients through procedures much better. There are some improvements that could be made, but getting rid of needles and wires will help with a number of those things.”
Screening is key
Early detection of breast cancer increases treatment options and survival rates. The University of Cincinnati Cancer Center's Mobile Mammography Unit is equipped with the latest in mammogram screening technology and offers a comfortable registration area, waiting space and private changing room.
Screenings typically take 15 minutes, with results sent to providers within 1-3 business days.
Other study authors include Elizabeth Shaughnessy, MD, PhD; Leah Hefelfinger; Alexander Doherty; Rifat Wahab, DO; and Lauren Rosen, MD. The authors declare no relevant conflicts of interest and have no financial interests with Elucent, the company that makes SmartClips.
Featured photo at top of University of Cincinnati Cancer Center breast cancer surgeons working in the operating room. Photo/Colleen Kelley/UC Marketing + Brand.
Related Stories
UC cancer research presented at national meeting
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
UC study: Immunotherapy drug did not increase surgery complications
September 7, 2022
University of Cincinnati researchers recently published study results in JAMA Otolaryngology showing that administering immunotherapy drug pembrolizumab before surgery for oral cavity cancer did not increase rates of complication during and after surgery.
New trial tests chemotherapy regimen following pancreatic cancer surgery
May 19, 2023
The University of Cincinnati Cancer Center's Syed Ahmad, MD, is the national principal investigator for a phase 2 trial testing the effectiveness of chemotherapy treatment following surgery for a subset of pancreatic cancer patients.
Research Evangelist: UC expert discusses improving accessibility to lung cancer treatments
November 28, 2023
The University of Cincinnati Cancer Center's Robert Van Haren joined the Research Evangelist podcast to discuss advancements in lung cancer care and research to improve accessibility to treatments.
UC study: ‘GPS’ seed devices effective in localizing breast tumors
October 30, 2023
University of Cincinnati Cancer Center researchers found a seed device that acts as a GPS for surgeons to locate and remove breast and lymph node tumors was safe and effective.
UC study: Real-time navigation a useful tool for liver cancer procedures
February 29, 2024
A University of Cincinnati Cancer Center study published in the journal JAMA Network Open found real-time navigation is a useful tool for surgeons performing ablation procedures to destroy tumors in the liver.
Wall Street Journal: More women with breast cancer could skip harsh radiation
February 16, 2023
The University of Cincinnati Cancer Center's Sara Medek and Elizabeth Shaughnessy were featured in a Wall Street Journal article commenting on a recent study that found more older women with low-risk breast cancer could forgo radiation after surgery to avoid further side effects.
MedPage Today: Promising results for living donor transplants
April 5, 2022
The University of Cincinnati's Shimul Shah, MD, was featured in a MedPage Today article highlighting recent research on the success of living donor transplants for patients with unresectable colorectal cancer liver metastases.
55KRC: Death of Olivia Newton-John highlights breast cancer survivorship
August 15, 2022
The University of Cincinnati's Elizabeth Shaughnessy, MD, PhD, joined 55KRC's Simply Medicine program to discuss breast cancer survivorship and screening in light of the recent death of actress and singer Olivia Newton-John.
WCPO: Middletown man hopes prostate cancer diagnosis inspires other to get screened
September 18, 2023
Patient Reverend Michael Bailey and University of Cincinnati Cancer Center member Nilesh Patil spoke with WCPO about the importance of screening during Prostate Cancer Awareness Month.